Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion with Nicotine Patch and CBT for Smoking Cessation in Depressed Individuals
NCT00142831Phase 4Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Apr 1999
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Bupropion Group with Placebo Group (2 arms). Primary endpoint: 7 day point prevalence of cigarette abstinence at 13 weeks. Started Apr 1999; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00142831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142831.